Envoy Therapeutics' Debt Round

Envoy Therapeutics raised a round of funding on November 23, 2009. Investors include Takeda Ventures.

Envoy Therapeutics aims to discover new drugs with efficacy and fewer side effects than existing treatments. The companys bacTRAP technology enables the identification of proteins in vivo that are pro…

Articles about Envoy Therapeutics' Debt Round: